BCM
AVNS

Bridgeway Capital Management’s Avanos Medical AVNS Stock Holding History

Bridgeway Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-272,186
Closed -$3.81M – 1241
2026
Q1 		$3.81M Sell
272,186
-39,293
-13% -$529K 0.08% 319
2025
Q4 		$3.5M Buy
311,479
+20,807
+7% +$238K 0.07% 336
2025
Q3 		$3.36M Buy
290,672
+67
+0% +$785 0.07% 367
2025
Q2 		$3.56M Buy
290,605
+9,006
+3% +$113K 0.08% 329
2025
Q1 		$4.04M Buy
281,599
+8,348
+3% +$130K 0.1% 286
2024
Q4 		$4.35M Buy
273,251
+127,591
+88% +$2.53M 0.1% 302
2024
Q3 		$3.5M Sell
145,660
-188,991
-56% -$4.32M 0.08% 367
2024
Q2 		$6.67M Sell
334,651
-1,320
-0.4% -$25.7K 0.16% 188
2024
Q1 		$6.69M Buy
335,971
+13,409
+4% +$259K 0.14% 230
2023
Q4 		$7.24M Buy
322,562
+14,784
+5% +$305K 0.16% 201
2023
Q3 		$6.22M Buy
307,778
+12,166
+4% +$276K 0.15% 215
2023
Q2 		$7.56M Buy
295,612
+4,774
+2% +$126K 0.18% 171
2023
Q1 		$8.65M Buy
290,838
+6,921
+2% +$201K 0.23% 116
2022
Q4 		$7.68M Buy
+283,917
New +$6.94M 0.2% 151
2017
Q3 		– Sell
-44,800
Closed -$1.76M – 1396
2017
Q2 		$1.76M Hold
44,800
– – 0.02% 622
2017
Q1 		$1.71M Hold
44,800
– – 0.02% 625
2016
Q4 		$1.66M Hold
44,800
– – 0.02% 638
2016
Q3 		$1.55M Hold
44,800
– – 0.02% 623
2016
Q2 		$1.46M Hold
44,800
– – 0.02% 639
2016
Q1 		$1.29M Buy
44,800
+37,800
+540% +$1.01M 0.02% 658
2015
Q4 		$234K Buy
+7,000
New +$218K ﹤0.01% 1262

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bridgeway Capital Management's AVNS Position: Q2 2026 in Review

Bridgeway Capital Management sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 272,186 shares — an estimated $3.81M sold.

Bridgeway Capital Management first reported a position in AVNS in Q4 2015 and held it in 21 quarters. The position peaked at $8.65M in Q1 2023. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Bridgeway Capital Management reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 272,186 Avanos Medical shares in Q2 2026, an estimated $3.81M.
  • Bridgeway Capital Management first reported a position in Avanos Medical in Q4 2015 and held it in 21 quarters.
  • Bridgeway Capital Management's Avanos Medical position peaked at $8.65M in Q1 2023.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.